Peripheral Administration of the Selective Inhibitor of Soluble Tumor Necrosis Factor (TNF) XPro®1595 Attenuates Nigral Cell Loss and Glial Activation in 6-OHDA Hemiparkinsonian Rats
Christopher J. Barnum, Xi Chen, Jaegwon Chung, Jianjun Chang, Martha Williams, Nelly Grigoryan, Raymond J. Tesi, Malú G. Tansey
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.3233/jpd-140410 ↗
- Volume · Issue · Pages
- 4 · 3 · 349-360
- Publisher
- IOS Press BV
- Article URL
- https://doi.org/10.3233/jpd-140410 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jan 2014
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jan 2014 | OpenAlex |
Keywords (as given): XPro1595; Parkinson's disease; neuroinflammation; 6-hydroxydopamine lesion; substantia nigra pars compacta; microglial activation; astrocyte activation; blood-brain barrier penetration; cerebrospinal fluid drug concentration; disease-modifying therapy
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Journal of Parkinson's Disease
- Publication date used
- 01 Jan 2014 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.